New BCMA-Directed Therapies Show Promise in Multiple Myeloma

(MedPage Today) -- Data presented at the American Society of Hematology (ASH) annual meeting highlighted advances in B-cell maturation antigen (BCMA)-directed therapies, including ABBV-383, a bispecific antibody with reduced toxicity and outpatient...